FIOCRUZ HIV prevention and treatment center in Rio de Janeiro
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
This center runs clinical trials of new HIV prevention and treatment approaches for people living with or at risk for HIV in Brazil.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fundacao Oswaldo Cruz NIH-funded |
| Lab location | 1 site (Rio de Janeiro, BRAZIL) |
| Project ID | NIH-11237053 on NIH RePORTER |
What this research studies
You would be joining clinical studies run by the FioTrials team at the Oswaldo Cruz Foundation (FIOCRUZ) in Rio de Janeiro, which conducts hospital-based trials following international good‑clinical‑practice standards. The unit recruits people living with HIV and people at risk, and studies new medicines, prevention strategies, and care approaches—sometimes including TB or hepatitis co-infections. Experienced investigators and junior researchers work together to manage study visits, safety monitoring, and laboratory testing for participants. Many trials at this site have supported regulatory approvals and changes in care practices.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV or people at risk for HIV who can attend study visits at the FIOCRUZ site in Rio de Janeiro and meet specific trial eligibility rules.
Not a fit: People who live far from Rio de Janeiro, who do not meet study eligibility criteria, or who are ineligible because of medical exclusions may not be able to participate or benefit directly.
Why it matters
Potential benefit: If successful, the work could bring better prevention tools, safer or more effective HIV treatments, and more trial access for people in Brazil.
How similar studies have performed: FIOCRUZ and affiliated networks have run multiple successful HIV and TB trials that informed treatment and prevention and contributed to licensure of new agents.
Where this research is happening
Rio de Janeiro, BRAZIL
- Fundacao Oswaldo Cruz — Rio de Janeiro, Brazil (Active)
Researchers
- Principal investigator: Grinsztejn, Beatriz — Fundacao Oswaldo Cruz
- Study coordinator: Grinsztejn, Beatriz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.